DE69432919D1 - Verfahren für den Nachweis spezifischer Polynukleotiden - Google Patents

Verfahren für den Nachweis spezifischer Polynukleotiden

Info

Publication number
DE69432919D1
DE69432919D1 DE69432919T DE69432919T DE69432919D1 DE 69432919 D1 DE69432919 D1 DE 69432919D1 DE 69432919 T DE69432919 T DE 69432919T DE 69432919 T DE69432919 T DE 69432919T DE 69432919 D1 DE69432919 D1 DE 69432919D1
Authority
DE
Germany
Prior art keywords
detection
methods
specific polynucleotides
polynucleotides
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69432919T
Other languages
English (en)
Other versions
DE69432919T2 (de
Inventor
Tetsu Hase
Harumi Masubuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eiken Chemical Co Ltd
Tanabe Seiyaku Co Ltd
Original Assignee
Eiken Chemical Co Ltd
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eiken Chemical Co Ltd, Tanabe Seiyaku Co Ltd filed Critical Eiken Chemical Co Ltd
Publication of DE69432919D1 publication Critical patent/DE69432919D1/de
Application granted granted Critical
Publication of DE69432919T2 publication Critical patent/DE69432919T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69432919T 1993-12-28 1994-12-21 Verfahren für den Nachweis spezifischer Polynukleotiden Expired - Fee Related DE69432919T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33786393 1993-12-28
JP33786393 1993-12-28

Publications (2)

Publication Number Publication Date
DE69432919D1 true DE69432919D1 (de) 2003-08-14
DE69432919T2 DE69432919T2 (de) 2004-05-27

Family

ID=18312699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69432919T Expired - Fee Related DE69432919T2 (de) 1993-12-28 1994-12-21 Verfahren für den Nachweis spezifischer Polynukleotiden

Country Status (3)

Country Link
US (1) US5849487A (de)
EP (1) EP0663447B1 (de)
DE (1) DE69432919T2 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) * 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
US6268146B1 (en) * 1998-03-13 2001-07-31 Promega Corporation Analytical methods and materials for nucleic acid detection
US6703211B1 (en) 1998-03-13 2004-03-09 Promega Corporation Cellular detection by providing high energy phosphate donor other than ADP to produce ATP
US6391551B1 (en) * 1998-03-13 2002-05-21 Promega Corporation Detection of nucleic acid hybrids
AU765428B2 (en) * 1998-03-13 2003-09-18 Promega Corporation Methods for determining the presence of nucleic acid target sequences and applications thereof
US6335162B1 (en) 1998-03-13 2002-01-01 Promega Corporation Nucleic acid detection
US6159693A (en) * 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
US6270973B1 (en) 1998-03-13 2001-08-07 Promega Corporation Multiplex method for nucleic acid detection
US6270974B1 (en) 1998-03-13 2001-08-07 Promega Corporation Exogenous nucleic acid detection
US6235480B1 (en) 1998-03-13 2001-05-22 Promega Corporation Detection of nucleic acid hybrids
US6277578B1 (en) * 1998-03-13 2001-08-21 Promega Corporation Deploymerization method for nucleic acid detection of an amplified nucleic acid target
US6312902B1 (en) 1998-03-13 2001-11-06 Promega Corporation Nucleic acid detection
US7090975B2 (en) 1998-03-13 2006-08-15 Promega Corporation Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
GB9823005D0 (en) * 1998-10-22 1998-12-16 Harbron Stuart Detection of amplified products in nucleic acid assays
JP3401201B2 (ja) * 1998-12-02 2003-04-28 東京応化工業株式会社 電子部品用基材の製造方法及びそれに用いるレジスト除去剤
AU774085B2 (en) * 1999-02-18 2004-06-17 Promega Corporation Multiplex method for nucleic acid detection
DK1471926T3 (da) 1999-06-01 2011-02-28 Baylor College Medicine Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
EP1218543A2 (de) * 1999-09-29 2002-07-03 Solexa Ltd. Polynukleotidsequenzierung
US6762018B1 (en) 1999-12-23 2004-07-13 Tetragen Sa Analysis of nucleotide polymorphisms at a site
JP4683811B2 (ja) 2000-05-01 2011-05-18 栄研化学株式会社 核酸合成反応産物の検出方法
US6824980B2 (en) 2000-06-08 2004-11-30 Xiao Bing Wang Isometric primer extension method and kit for detection and quantification of specific nucleic acid
JP3821773B2 (ja) * 2002-11-06 2006-09-13 富士写真フイルム株式会社 ピロ燐酸定量用乾式分析素子
US20040018502A1 (en) * 2001-06-14 2004-01-29 Yoshihiko Makino Method for analyzing a target nucleic acid fragment and a kit for analyzing a target nucleic acid fragment
US20060073530A1 (en) * 2001-08-15 2006-04-06 Olaf Schneewind Methods and compositions involving sortase B
JP4318296B2 (ja) * 2001-08-29 2009-08-19 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション 標識ヌクレオシドポリホスフェート
US7256019B2 (en) * 2001-08-29 2007-08-14 Ge Healthcare Bio-Sciences Corp. Terminal phosphate blocked nucleoside polyphosphates
US7560254B2 (en) 2001-08-29 2009-07-14 Ge Healthcare Bio-Sciences Corp. Allele specific primer extension
US7033762B2 (en) 2001-08-29 2006-04-25 Amersham Biosciences Corp Single nucleotide amplification and detection by polymerase
US7052839B2 (en) * 2001-08-29 2006-05-30 Amersham Biosciences Corp Terminal-phosphate-labeled nucleotides and methods of use
US7223541B2 (en) * 2001-08-29 2007-05-29 Ge Healthcare Bio-Sciences Corp. Terminal-phosphate-labeled nucleotides and methods of use
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
WO2003064625A2 (en) 2002-02-01 2003-08-07 Sequitur, Inc. Oligonucleotide compositions with enhanced efficiency
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
WO2003078655A1 (fr) * 2002-03-19 2003-09-25 Matsushita Electric Industrial Co., Ltd. Procede de detection d'acide phosphorique inorganique, acide pyrophosphorique et acide nucleique et typage de sequences de polymorphisme de nucleotide (psn) simple d'adn
CN101912421A (zh) 2002-08-12 2010-12-15 杰能斯有限公司 涉及痘病毒和癌的方法及组合物
CA2496462C (en) * 2002-08-29 2014-01-28 Amersham Biosciences Corp Allele specific primer extension
AU2004277589A1 (en) * 2003-09-30 2005-04-14 Perkinelmer Las, Inc. Compositions and processes for genotyping single nucleotide polymorphisms
EP1802775B1 (de) 2004-09-14 2010-05-26 The Regents of the University of Colorado Auf genetischem targeting basierendes verfahren zur behandlung mit bucindolol
US9040237B2 (en) * 2005-03-04 2015-05-26 Intel Corporation Sensor arrays and nucleic acid sequencing applications
US9695472B2 (en) * 2005-03-04 2017-07-04 Intel Corporation Sensor arrays and nucleic acid sequencing applications
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
WO2007030668A2 (en) 2005-09-07 2007-03-15 Jennerex Biotherapeutics Ulc Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
CA2663034C (en) 2006-09-15 2016-05-03 Ottawa Health Research Institute Oncolytic rhabdovirus
GB0703997D0 (en) * 2007-03-01 2007-04-11 Oxitec Ltd Methods for detecting nucleic sequences
US8211673B2 (en) * 2008-02-04 2012-07-03 Life Technologies Corporation Composition and method for sequencing nucleic acid
EP2789689B1 (de) 2009-06-29 2016-04-27 Luminex Corporation Chimäre Primer mit Haarnadel-Konformationen und Verfahren zur Verwendung davon
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
US9512481B2 (en) 2009-09-11 2016-12-06 The Regents Of The University Of Colorado, A Body Corporate Polymorphisms in the PDE3A gene
CA2774144C (en) 2009-09-14 2018-02-13 Jennerex, Inc. Oncolytic vaccinia virus combination cancer therapy
CN102858959B (zh) 2009-12-10 2016-02-24 渥太华医院研究院 溶瘤弹状病毒
CA2822747A1 (en) 2009-12-23 2011-06-30 Arca Biopharma, Inc. Use of s-(6-nitro-oxi-hexahydro-furo[3,2-b]thioacetate in the treatment of cardiovascular disorders associated with oxide synthase dysfunction
US8962279B2 (en) * 2009-12-30 2015-02-24 Intel Corporation Solid-phase chelators and electronic biosensors
US8500979B2 (en) * 2009-12-31 2013-08-06 Intel Corporation Nanogap chemical and biochemical sensors
US8674086B2 (en) 2010-06-25 2014-03-18 Intel Corporation Nucleotides and oligonucleotides for nucleic acid sequencing
US8715932B2 (en) 2010-08-20 2014-05-06 Intel Corporation Nucleic acid sequencing
US8444835B2 (en) 2010-09-09 2013-05-21 Intel Corporation Electronic and fluidic interface
EP2633076B1 (de) 2010-10-28 2016-07-27 Life Technologies Corporation Chemisch verstärkte primerzusammensetzungen, verfahren und kits
BR112013017096A2 (pt) 2011-01-04 2020-09-01 Jennerex Inc. composição e métodos de indução de resposta citotóxica dependente de complemento mediado por anticorpo específico de tumor em animal tendo tumor, de geração de anticorpos in vivo, de inibição do crescimento ou morte de célula de câncer, para tratar indivíduo com câncer, para adaptar de terapia de câncer para indivíduo com câncer e para identificar antígeno específico de tumor
US20140057295A1 (en) 2011-02-28 2014-02-27 Barbara J. Stegmann Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
AU2012226530B2 (en) 2011-03-08 2016-12-01 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
WO2012167382A1 (en) 2011-06-08 2012-12-13 Children's Hospital Of Eastern Ontario Research Institute Inc. Compositions and methods for glioblastoma treatment
US10040853B2 (en) 2011-09-09 2018-08-07 Fred Hutchinson Cancer Research Center Methods and compositions involving NKG2D inhibitors and cancer
DE112011105961T5 (de) 2011-12-15 2014-09-18 Intel Corporation Nanolückenwandler mit Diamantelektroden
WO2013100949A1 (en) 2011-12-28 2013-07-04 Intel Corporation Nanogap transducers with selective surface immobilization sites
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
RU2684211C2 (ru) 2013-02-21 2019-04-04 Тёрнстоун Лимитед Партнершип Композиция вакцины
BR112016007391A2 (pt) 2013-10-03 2017-08-01 Oklahoma Med Res Found biomarcadores da atividade, da intensidade e da fase aguda da doença lúpus eritematoso sistêmico
US20180057839A1 (en) 2014-11-26 2018-03-01 The Regents Of The University Of California Therapeutic compositions comprising transcription factors and methods of making and using the same
US20190390278A1 (en) 2017-01-26 2019-12-26 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
CA3116539C (en) 2018-10-18 2023-10-03 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
WO2020089841A1 (en) 2018-10-31 2020-05-07 Garcia Joe G N Biomarkers and methods of use for radiation-induced lung injury

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464359A (en) * 1981-04-10 1984-08-07 Research Corporation (2'-5')-Oligo (3'-deoxyadenylate) and derivatives thereof
GB8311018D0 (en) * 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4971903A (en) * 1988-03-25 1990-11-20 Edward Hyman Pyrophosphate-based method and apparatus for sequencing nucleic acids
FR2650840B1 (fr) * 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US5102784A (en) * 1990-05-04 1992-04-07 Oncor, Inc. Restriction amplification assay
US5210015A (en) * 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
FR2674254B1 (fr) * 1991-03-20 1995-10-06 Univ Reims Champagne Ardenne Detection non radioactive de la presence d'un acide nucleique determine dans un echantillon biologique.
GB9208733D0 (en) * 1992-04-22 1992-06-10 Medical Res Council Dna sequencing method
GB9210168D0 (en) * 1992-05-12 1992-06-24 Cemu Bioteknik Ab Method of sequencing dna

Also Published As

Publication number Publication date
US5849487A (en) 1998-12-15
DE69432919T2 (de) 2004-05-27
EP0663447A3 (de) 1998-06-03
EP0663447A2 (de) 1995-07-19
EP0663447B1 (de) 2003-07-09

Similar Documents

Publication Publication Date Title
DE69432919D1 (de) Verfahren für den Nachweis spezifischer Polynukleotiden
DE69432015D1 (de) Verfahren
DE69327454T2 (de) Analytisches verfahren
DE69207580D1 (de) Verfahren zum DNS-Nachweis
DE69309179D1 (de) Verfahren für Navigationshilfe
DE69431317D1 (de) DNS-Analyse Verfahren
DE69424076T2 (de) Verfahren zum Nachweisen von Luciferase
DE69302420D1 (de) Verfahren zum Fotoformen
DE69529936T2 (de) Verfahren zur Quantifizierung von spezifischen Verbindungen
DE69735087D1 (de) Verfahren zum Detektion von Methicillinresistenten Staphylococcen
DE59205867D1 (de) Verfahren zur Erkennung von Verbrennungsaussetzern
DE69414001D1 (de) Bestimmungsmethode
DE4403348B8 (de) Verfahren zur Detektion von Fehlzündungen
DE69331151T2 (de) Verfahren zur Erkennung von Fehlzündungen
DE69425761T2 (de) Topographisches Verfahren
DE69619231T2 (de) Verfahren zum deinken
DE59406291D1 (de) Verfahren zur klopferkennung
DE69406945D1 (de) Katalytisches verfahren
DE59500133D1 (de) Verfahren zur Erkennung von seitenverkehrt angeschlossenen Lambda-Sonden
DE69418318D1 (de) Verfahren zur krafterzeugung
DE69521385T2 (de) Elektrophotographisches Verfahren
DE69324888D1 (de) Verfahren zum Nachweis von Phosphatase
DE59409831D1 (de) Oligonukleotide für den Nachweis von Enterobacteriaceae
BR9407815A (pt) Método de ensaio
DE69626460D1 (de) Verfahren zum Elektroplattieren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee